Irritable bowel syndrome sits at a frustrating intersection of physical and neurological dysfunction, and for the roughly 10–15% of adults worldwide who live with it, effective management remains elusive. The gut-brain axis — the bidirectional communication highway linking intestinal function to central and autonomic nervous system activity — has long been theorized as a therapeutic target, but rigorous trial data on accessible behavioral interventions have been scarce. This study offers some of the most methodologically robust evidence yet that yoga can meaningfully shift the physiology underlying IBS.
In this randomized controlled trial of 202 adults aged 18–45 meeting Rome IV diagnostic criteria for IBS, participants assigned to a structured 3-month yoga program showed statistically significant improvements across several autonomic markers compared to controls. Resting heart rate declined (p < 0.0001), the low-to-high frequency ratio of heart rate variability — a proxy for sympathovagal balance — also fell significantly (p < 0.0001), and the Valsalva ratio improved (p = 0.0100), collectively indicating a shift toward parasympathetic dominance. These objective physiological changes were accompanied by improved IBS-specific quality of life scores.
What distinguishes this trial from earlier yoga-IBS research is both the sample size — 202 participants is substantive for a behavioral RCT — and the use of multiple convergent autonomic measures rather than self-report alone. The findings align with the broader vagal tone hypothesis: practices that reduce sympathetic hyperactivity may dampen visceral hypersensitivity by modulating enteric nervous system signaling. This is mechanistically coherent with existing data on mindfulness-based therapies and gut motility. Key limitations include the Indian study population, which may limit generalizability; the absence of blinding inherent to yoga interventions; and a 3-month observation window that leaves durability of benefit unestablished. Still, for a low-cost, low-risk adjunct therapy, the autonomic signal here is genuinely noteworthy — incremental but clinically meaningful.
